Management expects net sales to be in the range of $342 to $348 million, gross margin to be approximately 52.5% to 54.5% and adjusted earnings per share in the range of $0.01 to $0.06 as it continues to invest in new product launches to drive future growth.
AngioDynamics Reaffirms FY23 Guidance
Management expects net sales to be in the range of $342 to $348 million, gross margin to be approximately 52.5% to 54.5% and adjusted earnings per share in the range
Related Posts
How To Earn $500 A Month From Ford Stock Ahead Of Q1 Earnings Report
April 18, 9:12 AM
Ford Motor Company (NYSE: F) is set to release earnings results for its first quarter on April 24.
GE HealthCare And University Hospitals Enter 10-Year Strategic Collaboration To Contemporize Its Imaging Fleet And Implement Enterprise Digital Solutions To Help Improve Patient Care And Optimize Processes
October 5, 10:01 AM
Technology-powered collaboration aims to deliver AI-enabled devices and digital solutions at the enterprise level to increase clinical and operational efficiencies, drive workflow enhancements and improve patient
Snap-On Q3: 5% Topline Growth, Changing Environment & More
October 19, 8:53 AM
Snap-On Inc (NYSE: SNA) reported